What a Blood Panel Actually Tells You

You get a blood panel back. Everything is in range. The doctor says it looks fine.

It might be. But "in range" is a much weaker statement than it sounds, and knowing what it actually means changes what you do with the result.

#What a reference range is

Usually the middle 95% of whoever walked into that lab. Not a health target — a description of a population, and the population getting blood drawn is not a healthy one.

Which means "normal" quietly encodes the diseases of the people being measured. A number can sit comfortably inside the range while the process it measures has been going wrong for a decade.

The gap between reference and optimal is where most preventable disease lives.

#The lipid panel

The standard panel gives you total cholesterol, LDL-C, HDL-C and triglycerides. Two of those matter, one is nearly useless, and the number that matters most usually isn't there.

ApoB is the one to ask for. Atherosclerosis is a particle-driven disease. Every atherogenic lipoprotein — LDL, VLDL, IDL, Lp(a) — carries exactly one ApoB molecule, so ApoB is a direct particle count. LDL-C measures the cholesterol cargo those particles happen to be carrying, which is a different quantity. Two people with identical LDL-C can differ substantially in particle number, and it's the particles that penetrate the endothelium, get retained by proteoglycan binding, oxidise, and start the foam-cell cascade.

Reference: under 130 mg/dL. Optimal: under 80. Elite: under 60.

Stop optimising HDL. Mendelian randomisation — using genetic variants as a natural experiment — shows that raising HDL pharmacologically doesn't reduce cardiovascular events. It's a marker of something else, not a lever.

Triglycerides under 80 rather than the reference 150. High triglycerides with low HDL is a fairly reliable metabolic-dysfunction signature even when glucose looks fine.

#The metabolic panel, and its blind spot

Fasting glucose and HbA1c are standard. Both are lagging indicators.

Fasting insulin is the most under-ordered test in medicine. Glucose stays normal for years while insulin climbs to keep it there — and the compensation is the disease process. It is completely invisible on a glucose-only panel. By the time fasting glucose rises, beta-cell function has usually been declining for a decade.

Look at the ranges together:

The upper bound of "normal" insulin is more than six times the optimal value. That range is not a target; it's barely even a constraint.

ALT under 25 U/L, not under 40. It's a usable proxy for liver fat, and the standard cutoff is far too permissive to catch early accumulation.

#The one you need once, ever

Lipoprotein(a). Roughly 90% genetically determined, elevated in about one in five people, and it independently multiplies cardiovascular risk. It is almost never on a standard panel.

You need it a single time in your life. It won't meaningfully change, and lifestyle won't move it. But it changes how aggressive every other cardiovascular target should be — if it's high, the ApoB target tightens considerably, and that's a decision you make once and act on for forty years.

One test. Most people never get it.

#Two more worth adding

Omega-3 index — the percentage of red blood cell fatty acids that are EPA and DHA. One of the better-validated nutritional biomarkers; below 4% associates with the highest cardiovascular risk, above 8% is the target. Rarely standard.

RBC magnesium, not serum. Serum magnesium is tightly buffered and stays normal during genuine deficiency, because the body will pull it out of bone and tissue to hold the serum number steady. The serum test can't detect the thing you're testing for.

#How to actually read a result

Trend beats any single draw. Same lab, fasted, same time of day, several points. Biological variation between draws is larger than most people assume, and a single value moving is usually noise.

Decide in advance what would make you act. Dense measurement without a pre-committed decision rule generates apparent trends indistinguishable from noise — this is the specific criticism the field's most credible researchers level at high-profile self-experimenters, and it applies just as well to one panel a year.

An abnormal value belongs with a doctor, not a spreadsheet. Everything above is about reading a normal result more carefully. It is not a substitute for someone who can examine you.

---

This comes out of an ongoing protocol. The research behind it — every mechanism, every source tier, and an append-only record of everything it has gotten wrong — is at /protocol.